Rise Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-1,556
Closed -$8.06K – 1113
2025
Q3
$8.06K Buy
1,556
+22
+1% +$126 ﹤0.01% 1081
2025
Q2
$9.1K Buy
1,534
+19
+1% +$114 ﹤0.01% 1037
2025
Q1
$12.5K Buy
1,515
+483
+47% +$4.05K 0.01% 833
2024
Q4
$8.52K Sell
1,032
-129
-11% -$1.03K ﹤0.01% 1009
2024
Q3
$8.88K Buy
1,161
+11
+1% +$101 ﹤0.01% 1024
2024
Q2
$11.9K Buy
1,150
+10
+0.9% +$110 0.01% 940
2024
Q1
$13.6K Buy
1,140
+1,003
+732% +$11.1K 0.01% 918
2023
Q4
$1.48K Buy
137
+1
+0.7% +$12 ﹤0.01% 486
2023
Q3
$1.88K Buy
+136
New +$1.99K ﹤0.01% 476

Other funds holding PTEN

Rise Advisors's PTEN Position: Q4 2025 in Review

Rise Advisors sold out of Patterson-UTI (PTEN) in Q4 2025, closing a stake of 1,556 shares — an estimated $8.06K sold.

Rise Advisors first reported a position in PTEN in Q3 2023 and held it in 9 quarters. The position peaked at $13.6K in Q1 2024. 373 funds tracked by Wall St. Rank hold PTEN as of Q4 2025.

  • Rise Advisors reported no remaining Patterson-UTI position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 1,556 Patterson-UTI shares in Q4 2025, an estimated $8.06K.
  • Rise Advisors first reported a position in Patterson-UTI in Q3 2023 and held it in 9 quarters.
  • Rise Advisors's Patterson-UTI position peaked at $13.6K in Q1 2024.
  • 373 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.